Literature DB >> 19470519

TRAF-interacting protein with a forkhead-associated domain B (TIFAB) is a negative regulator of the TRAF6-induced cellular functions.

Takayuki Matsumura1, Junko Kawamura-Tsuzuku, Tadashi Yamamoto, Kentaro Semba, Jun-Ichiro Inoue.   

Abstract

Tumour necrosis factor receptor-associated factor (TRAF)-interacting protein with a forkhead-associated domain (TIFA) activates TRAF6 to induce NF-kappaB activation. TIFA-related protein, TIFAB, is highly expressed in the spleen and inhibits TIFA-mediated TRAF6 activation. However, little is known about cell types that express TIFAB and its function in those cells. Here, we show that TIFAB is mainly expressed in B cells rather than T cells in the spleen and that the expression level was much higher in dendritic cells (DCs) and macrophages than that in splenic lymphocytes. TIFAB expression was downregulated when B cells, DCs or macrophages were stimulated by TRAF6-mediated proliferative or maturation signals including those emanating from CD40, sIgM and TLRs. Furthermore, microinjection experiments using NIH3T3 cells revealed that TIFAB inhibited entry into the S phase of the cell cycle. Our results suggest that TIFAB could act as a negative regulator of the TRAF6-induced cellular function such as B cell proliferation and maturation of DCs and macrophages.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19470519     DOI: 10.1093/jb/mvp080

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  10 in total

1.  Genetic dissection of TLR9 reveals complex regulatory and cryptic proinflammatory roles in mouse lupus.

Authors:  Claire Leibler; Shinu John; Rebecca A Elsner; Kayla B Thomas; Shuchi Smita; Stephen Joachim; Russell C Levack; Derrick J Callahan; Rachael A Gordon; Sheldon Bastacky; Ryutaro Fukui; Kensuke Miyake; Sebastien Gingras; Kevin M Nickerson; Mark J Shlomchik
Journal:  Nat Immunol       Date:  2022-09-23       Impact factor: 31.250

2.  TIFA upregulation after hypoxia-reoxygenation is TLR4- and MyD88-dependent and associated with HMGB1 upregulation and release.

Authors:  Ning Ding; Yong Zhang; Patricia A Loughran; Qingde Wang; Allan Tsung; Timothy R Billiar
Journal:  Free Radic Biol Med       Date:  2013-05-28       Impact factor: 7.376

3.  A boy with homozygous microdeletion of NEUROG1 presents with a congenital cranial dysinnervation disorder [Moebius syndrome variant].

Authors:  Julia C Schröder; Anne K Läßig; Danuta Galetzka; Angelika Peters; John C Castle; Stefan Diederich; Ulrich Zechner; Wibke Müller-Forell; Annerose Keilmann; Oliver Bartsch
Journal:  Behav Brain Funct       Date:  2013-02-18       Impact factor: 3.759

4.  RNA-seq characterization of spinal cord injury transcriptome in acute/subacute phases: a resource for understanding the pathology at the systems level.

Authors:  Kenian Chen; Shuyun Deng; Hezuo Lu; Yiyan Zheng; Guodong Yang; Dong Kim; Qilin Cao; Jia Qian Wu
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

5.  Helicobacter pylori modulates host cell responses by CagT4SS-dependent translocation of an intermediate metabolite of LPS inner core heptose biosynthesis.

Authors:  Saskia C Stein; Eugenia Faber; Simon H Bats; Tatiana Murillo; Yvonne Speidel; Nina Coombs; Christine Josenhans
Journal:  PLoS Pathog       Date:  2017-07-17       Impact factor: 6.823

6.  Epigallocatechin-3-gallate(EGCG) suppresses melanoma cell growth and metastasis by targeting TRAF6 activity.

Authors:  Jianglin Zhang; Zhou Lei; Zunnan Huang; Xu Zhang; Youyou Zhou; Zhongling Luo; Weiqi Zeng; Juan Su; Cong Peng; Xiang Chen
Journal:  Oncotarget       Date:  2016-11-29

7.  TIFAB Regulates USP15-Mediated p53 Signaling during Stressed and Malignant Hematopoiesis.

Authors:  Madeline Niederkorn; Kathleen Hueneman; Kwangmin Choi; Melinda E Varney; Laurel Romano; Mario A Pujato; Kenneth D Greis; Jun-Ichiro Inoue; Ruhikanta Meetei; Daniel T Starczynowski
Journal:  Cell Rep       Date:  2020-02-25       Impact factor: 9.423

8.  TIFAB accelerates MLL-AF9-Induced acute myeloid leukemia through upregulation of HOXA9.

Authors:  Jinming Zhao; Yan Xiu; Lin Fu; Qianze Dong; Nicholas Borcherding; Yang Wang; Qingchang Li; Nilushi S De Silva; Ulf Klein; Brendan F Boyce; Chen Zhao
Journal:  iScience       Date:  2021-11-12

9.  Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor-TRAF6 signaling.

Authors:  Melinda E Varney; Madeline Niederkorn; Hiroyasu Konno; Takayuki Matsumura; Jin Gohda; Nobuaki Yoshida; Taishin Akiyama; Susanne Christie; Jing Fang; David Miller; Andres Jerez; Aly Karsan; Jaroslaw P Maciejewski; Ruhikanta A Meetei; Jun-ichiro Inoue; Daniel T Starczynowski
Journal:  J Exp Med       Date:  2015-10-12       Impact factor: 14.307

10.  Structural analysis of TIFA: Insight into TIFA-dependent signal transduction in innate immunity.

Authors:  Teruya Nakamura; Chie Hashikawa; Kohtaro Okabe; Yuya Yokote; Mami Chirifu; Sachiko Toma-Fukai; Narushi Nakamura; Mihoko Matsuo; Miho Kamikariya; Yoshinari Okamoto; Jin Gohda; Taishin Akiyama; Kentaro Semba; Shinji Ikemizu; Masami Otsuka; Jun-Ichiro Inoue; Yuriko Yamagata
Journal:  Sci Rep       Date:  2020-03-20       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.